Arvind Utchanah
Vermogen: 886 607 $ op 30-09-2026
Vermogen: 886 607 $ op 30-09-2026
Arvind Utchanah is currently Chief Financial Officer at Knight Therapeutics, Inc. since 2020.
Formerly, Mr. Utchanah was Director-Finance, Accounting & Financial Planning at Paladin Labs, Inc. from 2012 to 2016.
Education includes undergraduate studies at McGill University and graduate studies at Concordia University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-09-2026 | 118.689 ( 0,12% ) | 886 607 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| KNIGHT THERAPEUTICS INC. | Financieel Directeur/CFO | 30-03-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| PALADIN LABS INC. | Financieel Directeur/CFO | 01-06-2016 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Paladin Labs, Inc.
Paladin Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceuticals | Health Technology |
Knight Therapeutics, Inc.
Knight Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acquires, sells and markets prescription and over-the-counter pharmaceutical products | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Concordia University
Concordia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau